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ABSTRACT 
 
Determining Factors Influencing Nuclear Envelope and Nuclear Pore Complex Structure. (May 
2013) 
Sushanth Gouni 
Department of Biology 
Texas A&M University 
 
Research Advisor: Dr. Kathryn J Ryan 
Department of Biology 
The cell’s nuclear envelope (NE) has pores that are stabilized by nuclear pore complexes (NPC), 
large proteinaceous structures whose function is to mediate transport between the nucleus and 
cytoplasm. Although the transport process is well studied, the mechanism of NPC assembly from 
its protein constituents (nucleoporins) is less understood. To investigate NPC biogenesis, I 
investigated mutants that result in defective NPCs in Saccharomyces cerevisiae. 
 
First, I examined mutants in the GPI anchor pathway (gpi1) that resulted in mislocalized 
nucleoporins by testing two models: gpi1 mutants cause either misregulation of N-linked 
glycosylation or alter membrane properties. To test the models, I combined gpi1 mutants with a 
nucleoporin mutant that is susceptible to disruption of glycosylation or with mutants in 
membrane bending proteins.  Select double mutant of each class rescued the growth phenotype 
of the single mutants. These results indicate that both of the models play a role in NPC assembly. 
Secondly, we found the proteasome, a complex responsible for degrading proteins is involved in 
NPC assembly.  In order to further investigate interactions between the NPC and the proteasome, 
I combined the proteasomal mutant with 3 classes of nuclear pore assembly (npa) mutants to test 
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for synergistic interactions. Positive interactions were observed as the proteasome mutant 
rescued a temperature sensitive npa mutant providing further evidence for the role of the 
proteasome in NPC assembly 
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NOMENCLATURE 
 
NPC   Nuclear Pore complex 
GPI   Glylcosylphosphatidylinositol 
Nup   Nucleoporin 
INM   Inner nuclear membrane 
ONM   Outer nuclear membrane 
NE   Nuclear Envelope 
POM   Pore outer membrane 
Kaps   karyopherins 
GTP   Guanosine-5’ triphosphate 
GlcNAc-PI  N-acetylglucosamine phosphatidylinositol 
GlcNAC  N-acetylglucosamine 
UDP-GlcNAc  Uridine diphosphate N-acetylglucosamine 
ER   Endoplasmic Reticulum 
RTN   Reticulon 
npa    nuclear pore assembly 
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CHAPTER I 
INTRODUCTION 
 
The eukaryotic cell is divided into membrane enclosed organelles that enable efficient 
performance of cellular tasks in specialized microenvironments. The nucleus of the cell is one of 
these specialized compartments that houses the genome and is separated from the cytoplasmic 
contents of the cell by a double membrane structure called the nuclear envelope (NE). 
 
The NE is composed of two distinct lipid bilayers, the inner nuclear membrane (INM) and outer 
nuclear membrane (ONM) that bend sharply and fuse together at multiple locations resulting in 
cylindrical fissures called nuclear pores.  These nuclear pores serve as sites for the assembly of 
one of the largest and most complex proteinaceous assemblies in the cell called the nuclear pore 
complexes (NPC), whose primary function is to facilitate transport of macromolecules between 
the nucleoplasm and the cytoplasm. 
 
The Nuclear pore complex. 
The Saccharomyces cervisiae NPC is about 40MDa  (Hoelz, Debler et al. 2011) and is composed 
of approximately 30 proteins (nucleoporins) that are present in multiple copies that result in 
about 500-1000 protein molecules in a fully intact NPC (Hoelz, Debler et al. 2011).The NPC 
structure is well conserved across vertebrates and invertebrates. It consists of two coaxial rings, 
connected by eight symmetrical spokes that lie perpendicular to the plane of the NE. These 
spokes come together and form the coaxial inner and outer membrane rings,  forming a central 
channel that serves as a transport channel (Strambio-De-Castillia, Niepel et al. 2010). Two sets 
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of fibrils are present at the ends of these rings, with one set extending out into the cytoplasm and 
the other set forming a basket like structure on the nucleoplasmic side (Aitchison and Rout 
2012). 
 
The nucleoporin proteins (nups) are divided into four categories:  Pore membrane protein 
(POMs) that span the pore membrane and function to anchor the NPC to the NE,   core scaffold 
nups that make up the inner and outer rings, phenylalanine-glycine (FG) nups that make up about 
11 of the 30 nups that are present along the inner surface of the spokes and the fibrils extending 
into both the nucleoplasm and the cytoplasm and linker nups that help anchor the FG nups. 
These nucleoporins are distributed into particular sub-structural domains in the NPC (Strambio-
De-Castillia, Niepel et al. 2010) and thus form a massive proteinaceous complex that is 
embedded in the NE. 
 
 Function of the NPC 
Transport between the nucleus and the cytoplasm is essential as various proteins and cargo 
molecules need to be shuttled back and forth. The principal function of the NPC is to facilitate 
transport of these macromolecules by acting as a highly selective barrier. Molecules that are <40 
kDa can freely diffuse across the NPC but larger proteins and mRNA trafficking is controlled by 
active transport that requires transport signals and nuclear transport factors. The FG sites present 
in the NPC serve as binding sites for transport factors called karyopherins (Kaps). Two of 
karyopherins α-Kap and β- Kap play a role in mediating transport. β- Kap, associates with the 
NLS motifs present on the cargo molecules and with the help of an adaptor molecule α-Kap, it 
binds to the  FG domain of the NPC. The cargo bound by the transport factor shuttles through the 
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NPC into the nucleus. Upon reaching its destination, the complex dissociates with the help of a 
small GTPase called Ran 
. 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
Ran exists in two confirmations: a GTP bound state that is present at high concentrations in the 
nucleus (maintained by Rcc1 (Prp20 in yeast), a Ran guanyl nucleotide exchange factor) and a 
 
Figure 1. Overall structure of the NPC. (a) Cryo-electron 
tomographic reconstruction of the NPC. (b) Schematic model of the 
NPC. (Hoelz A, et al. 2011) 
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GDP bound form (maintained by RanGAP (Rna1 in yeast), a GTPase-activating protein) 
localized to the cytoplasm. When the importin bound cargo enters the nucleus, RanGTP 
promotes the release of the cargo bound transport factor by binding to the Kaps. Nuclear export 
is mediated through Ran-GTP bound  to an exportin that in turn binds to the export cargo. This 
complex travels back through the NPC to the cytoplasm where the GTP is hydrolyzed resulting 
in dissociation of the complex .  
 
mRNA that is being synthesized in the nucleus eventually has to be shuttled to the cytoplasm so 
that it can be translated by the ribosome.  This transport is mediated by the NPC but it is 
independent of Kaps and Ran (Santos-Rosa, Moreno et al. 1998,Katahira, Strasser et al. 1999). 
The mRNA is packaged into ribonucleotide (RNP) particles that eventually associate with non-
kap transport factors which help the mRNA to translocate through the NPC. 
 
 NPC assembly 
NPC’s are complicated structures that have different domains consisting of about 500-1000 
proteins that need to be assembled into the NE to facilitate transport across the nucleus and the 
cytoplasm. NPC biogenesis is linked to cell cycle progression and the breakdown of the NE. In 
higher metazoans, the NE breaks down during mitosis and is retracted back into the ER so that 
the nucleus can undergo proper division. At this point the NPC’s have to disassemble from the 
ER and be portioned into vesicles. Some of the nucleoporins associate with the chromatin in the 
nucleus and form a pre-pore assembly complex (Walther, Alves et al. 2003); (Walther, Askjaer 
et al. 2003). Once the nucleus has successfully divided, the NE reforms from the ER and the pre-
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pore assembly acts as an anchor for the rest of the nucleoporins to come assemble and form a 
mature NPC. 
 
However, yeast undergo a “closed” mitosis where the NE never breaks down, implying that 
NPCs have to be inserted into an intact NE. Experiments conducted have shown that NPC 
assembly is continuous with ~70 NPCs present after mitosis to ~140 NPCs present at anaphase 
(Winey, Yarar et al. 1997).  This assembly process is still unclear and it comprises the main 
focus of my research. 
 
Work characterizing this assembly process has led to several breakthroughs in understanding the 
mechanism. A possible theory on assembly process was that NPC subcomponents precursors 
were accumulated in the NE which formed a scaffolding structure nucleoporins. Research 
conducted by D’Angelo et al (D'Angelo, Anderson et al. 2006) has shown that NPC assembly 
into an intact NE can be done independently of pre-existing NPCs,  and the assembly happens 
from both sides of the NE. Mutant analysis in components of the Ran cycle ( Ran, RanGEF, 
RanGAP, NTF2 and Kap95 all have defective NPC assembly phenotypes with mislocalized 
nucleoporins indicating that the Ran cycle is necessary for proper NPC assembly (Ryan, Zhou et 
al. 2007, Ryan, McCaffery et al. 2003).  
 
Recent work has also implicated the necessity of membrane bending reticulon proteins (RTNs) 
and in NPC assembly. Reticulon proteins function to stabilize pore curvature by forming hairpin 
like structures that wedge themselves into a leaflet of the bilayer (Oertle and Schwab 2003, 
Shibata, Voss et al. 2008). Deletion studies have indicated that these mutants have NPC 
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clustering phenotypes, nuclear import defects and synthetic lethality when combined with certain 
nucleoporins (Dawson, Lazarus et al. 2009). Membrane proteins that are involved in lipid 
homeostasis (Brr6, Apq12 and Brl1) also have defective NPC assembly phenotypes when they 
are perturbed implying that proper INM and ONM fusion is necessary for NPC biogenesis (de 
Bruyn Kops and Guthrie 2001). 
 
To gain further understanding in the NPC assembly process, mutation analysis of key genes that 
play a role in NPC assembly is necessary. A previous study that utilized Green Fluorescence 
Protein (GFP) tagged nucleoporins to screen for NPC defects identified mutants with defective 
NPC assembly (Ryan and Wente 2002).  The results from the screen showed that genes in the 
Glycosylphosphatidylinositol (GPI) anchor pathway play a role in NPC assembly (Ryan Lab, 
unpublished). 
 
GPI anchors 
Post-translational modification of proteins serves to increase the functionality that enable them to 
contribute to various biological processes. One of these modifications is adding a GPI anchor to 
the C termini of proteins in order to help them anchor to the cell wall. GPI anchors are 
synthesized in the Endoplasmic Reticulum (ER) in a multi step pathway involving ~28 proteins 
(Orlean and Menon 2007) (see Fig 2). Gpi1 is a protein involved in the synthesis of N-
acetylglucosamine phosphatidylinositol (GlcNAc-PI), the first key intermediate in the synthesis 
of GPI anchors by initiating the transfer of N-acetylglucosamine (GlcNAC) from uridine 
diphosphate N-acetylglucosamine (UDP-GlcNAc) to phosphatidylinositol. It has 6 predicted 
transmembrane domains and is localized to the ER membrane.  Point mutations in GPI1  that 
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induce premature stop codons at positions 212 and 536 result in truncated Gpi1 proteins that 
have a severe NPC assembly defect phenotype. 
In order to investigate why gpi1 mutants have these defects, I tested two models: 
1) Misregulation of N-linked Glycosylation causes NPC assembly defects in gpi1 mutants 
UDP-GlcNAc is a nucleotide sugar that is a common precursor for N-linked glycosylation, chitin 
and GPI anchor synthesis pathways. If GPI anchor biosynthesis is blocked at the Gpi1 stage, 
there is a tremendous increase in the amount of chitin in the cell (Ryan Lab data, unpublished); 
however it is unclear if there is mis-regulation of N-linked glycosylation. Previous work by 
Belanger et al. (Belanger, Gupta et al. 2005) has implicated the role of glycosylation in NPC 
function. Pom152 is a trans-membrane nucleoporin whose C-terminal segment is glycosylated 
(Tcheperegine, Marelli et al. 1999). 
 
When the glycosylation domains of this protein are perturbed and combined with a nup1Δ, a 
nucleoporin mutant that has a temperature sensitive growth phenotype and nuclear import  
 
 
 
 
 
 
 
 
 
Figure 2.  General scheme for GPI biosynthesis in the ER of yeast and mammals. 
(Orlean, P. and A. K. Menon  2007). 
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defects, synergistic interactions were observed as the pom152 mutant rescued the nup1Δ defects. 
Other evidence includes the deletion of a mannosyltransferase (ALG12) suppressing the nup1Δ 
defects and synergistic interactions  using chemical inhibitors affecting glycosylation rescuing 
nup82Δ  and nup1Δ defects (Belanger, Gupta et al. 2005). Since gpi1 mutants have similar 
defective NPC phenotypes as the nup1Δ, I combined gpi1 mutants with nup100Δ, a nucleoporin 
that has been shown to relieve nup1Δ defects. 
 
2) Gpi1 mutants alter membrane properties that result in defective NPC assembly. 
An alternative model as to how gpi1 mutants affect NPC assembly is that the mutants alter 
membrane properties. To test if changes in the membrane properties are the reason for NPC 
defects, I will examine mutants in RTN1 and RTN2. Rtn1 and Rtn2 are membrane shaping 
proteins with wedge shaped conformations that insert into the membrane, forcing a degree of 
curvature. If changes in the membrane properties are the reason for NPC defects, then mutations 
in rtn1 and rtn2 may have a synergistic effect of enhancing or suppressing the defects in gpi1 
mutant. 
 
Determine interactions between Proteasome and Nuclear pore complex 
The proteasome is a huge protein complex that serves to degrade various ubiquitin tagged protein 
targets. The catalytic activity of the proteasome is carried out by ATPase subunits that function 
in substrate unfolding. Mutations in RPT6, one of the ATPases of the proteasome have been 
shown to disrupt nucleoporin assembly in NPCs, causing nups to mislocalize and cluster at 
various regions in NE (Ryan Lab, unpublished). In order to further test the role of the proteasome 
in NPC assembly, I combined the rpt6 mutant with 3 different classes of npa mutants: clustering 
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mutants:  nup120 and nup133, nuclear transport factor mutants:  kap95 and rna1 and finally the 
GPI anchor mutants:  gab1, gpi1-s212 and gpi1-s537.  Testing these combinations for synergistic 
interactions has the potential to provide more insight into the role of the proteasome in NPC 
assembly. 
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CHAPTER II 
MATERIALS AND METHODS 
 
Growth of yeast strains 
Yeast were grown in YPD (yeast extract, peptone and 2% glucose) at room temperature unless 
otherwise stated. 
 Spot dilution assay 
Strains were grown to early log phase at room temperature. 5 x 10
5
 cells were harvested, serially 
diluted 5-fold and spotted on to the appropriate plates. 
Generating yeast strains: 
Transformation of Yeast 
Transformations were performed using the lithium acetate method as described in (Ito, Fukuda et 
al. 1983). 50ml of culture was growth with shaking to OD600 = ~0.5 to 0.7 (must be in log phase). 
Cells were washed with Lithium Acetate – TE solution and then transformations were setup with 
the appropriate miniprep DNA, carrier DNA and DMSO. 40% PEG-4000 in LiAC-TE was used 
to facilitate efficient transformation. After incubation (30C for 30 mins) and heat shock (42C for 
15 mins), cells were washed with TE and plated on selective media.  
Solutions for transformations: 
LiAC-TE Soln = Filter sterilized from combination of 10X stocks 
 10X TE = 0.1M Tris HCL, 0.01M EDTA pH 7.5 
 10X LiAC = 1 M LiAC pH 7.5 with diluted acetic acid 
40% PEG 4000 LiAC-TE soln : add PEG to appropriate 10X stocks LiAC and 10x TE. 
Filter sterilized 
Carrier DNA: Made from salon sperm or calf thymus DNA as per (Schiestl, Gietz 1989) 
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Yeast mating protocol 
Crosses were carried out with an appropriate MATa and MATα strains to generate a diploid 
MATa/α. After selection for diploids, the strains were placed in sporulation media where four 
haploid spores were produced from each meiosis. The ascus wall was digested using a 1:1 
mixture of Sorbitol and Zymolyase and the tetrad was seperated and germinated. After the 
tetrads formed colonies, they were genotyped by replica plating to various selective media to test 
for the appropriate markers.  
Microscopy 
GFP was used to visualize live cells using an Olympus microscope with a 100x oil-immersion 
objective.  
Cloning protocol for CDC31 
Gateway cloning, from Invitrogen was used for constructing a CDC31 expression plasmid. PCR 
with genomic DNA as a template and CDC31 oligos was used to generate an attB-flankedPCR 
product. A BP reaction was carried out using a donor vector combined with the attB-flanked 
PCR product to generate a Gateway entry clone. Electro competent E.coli cells were transformed 
using electroporation and incubated at 37C for 45 minutes and plated on LB+Tetracycline 
(50µg/ml). Positive colonies were selected and grown overnight in 2ml cultures. Miniprep of the 
E.coli was performed using QIAprep Spin Miniprep KIT (250) to isolate the Gateway entry 
clone. The CDC31 gene was then transferred to a Gateway Destination vector and the 
transformation of E.coli cells was followed just as indicated before. The cells were plated on 
LB+Carbinicillin (50µg/ml) plates and positive colonies were selected and grown overnight in 
2ml cultures. The Miniprep of the E.coli cells after the LR reaction was performed using the 
alkaline lysis method. The resulting plasmid was verified using a double restriction digest using 
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Xba and HindIII enzymes. The plasmid was further verified through sequencing using the Big 
Dye Kit according to the manufactures instructions.  
Table 1. Strain list 
Strain name Genotype 
YGS 73 GFP-nic96:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100 
KRY 1328 GFP-nic96:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  gpi1-S212 
KRY 1335 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  rtn1∆::KAN gpi1-S212 
KRY 1326 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  rtn1∆::KAN 
KRY 1360 trp1-1 ura3-1his3-11,15 leu2-3,112 can1-100 GFP-nic96:HIS3  gpi1-
S537:HPH 
KRY 1361 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  rtn1∆::KAN gpi1-S537:HPH 
KRY 1329 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  rtn∆2::KAN gpi1-S212 
KRY 1327 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100 rtn∆2::KAN 
KRY 1364 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100  rtn2∆::KAN gpi1-S537:HPH 
KRY 1331 nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-1 leu2-3,112 
can1-100 nup100::KAN gpi1-S212  
KRY 1308 nup100∆::KAN nic96-GFP:HIS3 ade2-1::ADE2 ura3-1 his3-11,15 trp1-
1 leu2-3,112 can1-100 
KRY 1359 trp1-1 ura3-1his3-11,15 leu2-3,112 can1-100 GFP-nic96:HIS3  gpi1-
S537:HPH nup100∆:KAN 
YGS 178 can1∆ ::STE2pr-Sp_his5 lyp1∆ ::STE3pr-LEU2 his3∆ leu2∆0 ura3∆0
  
KRY 922 can1∆ ::STE2pr-Sp_his5 lyp1∆ ::STE3pr-LEU2 his3∆1 leu2∆0 ura3∆0 
nic96-GFP:HPH rpt6/npa17:NAT 
KRY 992 can1∆ ::STE2pr-Sp_his5? lyp1∆ ::STE3pr-LEU2+ his3∆1 leu2∆0 
ura3∆0 nic96-GFP:HPH rpt6/npa17:NAT rpt6::kanR-tet07-TATA 
URA3::CMV-tTA MATa  met15-0?  
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KRY 991 can1∆ ::STE2pr-Sp_his5? lyp1∆ ::STE3pr-LEU2+ his3∆1 leu2∆0 
ura3∆0 nic96-GFP:HPH rpt6::kanR-tet07-TATA URA3::CMV-tTA 
MATa  met15-0?  
YGS 121 his3∆1 leu2∆0 met15∆0 ura3∆0 
KRY 1318 kap95-E126K  nic96-GFP:HPH his3 leu2 ura3 trp1-1 met15-0? can1-
100?   
KRY 1319 kap95-E126K  rpt6::kanR-tet07-TATA URA3::CMV-tTA nic96-
GFP:HPH his3 leu2 ura3 met15-0? can1-100?  
KRY 1404 His3∆1 leu2∆0 ura3∆0 met15∆0 nic96-GFP:HPH URA3::CMV-tTA 
KRY 1409 his3∆1 leu2∆0 met15∆0 ura3∆0 nup133∆::KAN nic96-GFP:HPH 
KRY 1295 nup133∆::KAN rpt6::kanR-tet07-TATA URA3::CMV-tTA nic96-
GFP:HPH his3∆1 leu2∆0 met15∆0? ura3∆0  
KRY 1332 nup120∆::HIS3 nic96-GFP:HPH his3 leu2 ura3 can1? met15-0?  
KRY 1334 nup120∆::HIS3  rpt6::kanR-tet07-TATA URA3::CMV-tTA nic96-
GFP:HPH his3 leu2 ura3 can1? met15-0 
KRY 89 trp1-1 ura3-1 his3-11,15 leu2-3,112 can1-100  rna1-S116F  
KRY 1418 nic96-GFP:HPH rpt6::kanR-tet07-TATA URA3::CMV-tTA rna1-S116F  
his- leu- 
KRY 1417 rpt6::kanR-tet07-TATA URA3::CMV-tTA nic96-GFP:HPH gab1-1 his- 
leu- 
KRY 1356 his3 leu2 lys2 trp1 ura3 nic96-GFP:HPH gab1-1  
KRY 1414 nic96-GFP:HPH rpt6::kanR-tet07-TATA URA3::CMV-tTA gpi1-S212 
his- leu- trp- 
KRY 1419 nic96-GFP:HPH rpt6::kanR-tet07-TATA URA3::CMV-tTA gpi1-
S537:HPH  leu-  
 
 
 
20 
 
CHAPTER III 
RESULTS 
 
Deletion of nup100 suppress defects in gpi1 mutants  
In order to investigate if gpi1 mutants cause misregulation of N-linked glycosylation, NUP100 
was deleted in strains that had point mutations in gpi1, which induce premature stop codons at 
amino acid positions 212 and 537, leading to truncated Gpi1 proteins. These gpi1 mutants exhibit 
temperature sensitivity at 34°. Strains were assayed for growth on rich media at 15°, 23°, 30°and 
34° by 5-fold serial dilutions. Positive interactions were observed at 15° with the gpi1-
S537/nup100Δ double mutant rescuing the cold sensitive growth phenotype of both the nup100Δ 
and the gpi1-S537 single mutants and the gpi1-s212/nup100Δ double mutant partially rescuing 
the nup100Δ mutant (See Fig. 3.) The gpi1-S537/nup100Δ also presented enhanced sickness at 
23° and 30° when compared to either of the single mutants. These results indicate that 
misregulation of N-linked glycosylation has a role in gpi1 mutants. 
 
 
 
 
 
 
 
 
Table 2: nup100 interactions with gpi1 mutants. Double mutants were generated and scored 
for growth against single mutants: “+” indicates rescue, “0/+” indicates partial rescue, “0” 
 
15° 
 
23° 
 
30° 
 
34° 
 
WT 
 
0 
 
0 
 
0 
 
0 
 
gpi1-S212 
 
0 
 
0 
 
0/- 
 
- 
 
gpi1-S212/nup100Δ 
 
0/+ 
 
0/- 
 
- 
 
- 
 
nup100Δ 
 
0/- - 
 
0 
 
0 
 
0 
 
gpi1-S537/nup100 Δ 
 
+ 
 
0 
 
0/- 
 
- 
 
gpi1-S537 
 
0/- 
 
0 
 
0/- 
 
- 
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indicates that cells were viable “0/-” indicates enhanced sickness, “0/--” indicates extreme 
sickness, “-” indicates lethality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Altering membrane properties and their effects in gpi1 mutants 
Reticulon proteins are hairpin structures that are responsible for the curvature of the ER. They 
have also been shown to play a role in NPC assembly. To test if altering membrane properties 
have synergistic effects on growth, RTN1 was deleted in strains with mutations in the GPI 
pathway. Strains were assayed for growth at 15°, 23°, 30°and 34°.  The gpi1-S212/rtn1Δ double 
mutant rescued the partial lethality of rtn Δ at 15° (See Fig. 4). The growth of this double mutant 
was better than the wild type at the lower temperature. Synthetically lethal interactions were 
observed in the gpi1-S537/rtn1Δ strain across all temperatures. To further explore the effects of 
            WT 
                          gpi1-S212 
          gpi1-S212/nup100Δ 
                           nup100Δ 
        gpi1-S537/nup100Δ 
           gpi1-S537 
                                 
                
           WT 
                         gpi1-S212 
          gpi1-S212/nup100Δ 
                            nup100Δ 
        gpi1-S537/nup100Δ 
            gpi1-S537 
                                 
                
Figure 3. nup100 interactions with gpi1 mutants. 5X serial dilutions on YPD plates 
15°                                                                       23° 
30°                                                                       34° 
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deleting reticulon proteins in the gpi1 mutants, rtn2 was deleted in gpi1 strains and assayed for 
growth as before.  The results were not dramatic as the double mutants were sicker compared to 
the single mutants. A faint partial rescue of the gpi1-S537/rtn2Δ mutant was seen at 23° when 
compared to the gpi1-s537 mutant (See Fig. 5). These results indicate that gpi1 mutants have 
altered membrane properties that can be restored by perturbing reticulon proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3: Rtn1 interactions with gpi1 mutants. Double mutants were generated and scored for 
growth against single mutants: “+” indicates rescue, “0/+” indicates partial rescue, “0” indicates 
that cells were viable “0/-” indicates enhanced sickness, “0/--” indicates extreme sickness, “-” 
indicates lethality. 
 
 
 
15° 
 
23° 
 
30° 
 
34° 
 
WT 
 
0 
 
0 
 
0 
 
0 
 
gpi1-S212 
 
0 
 
0 
 
0 
 
- 
 
gpi1-S212/rtn1Δ 
 
+ 
 
0 
 
0/- 
 
- 
 
rtn1Δ 
 
0/-  
 
0 
 
0 
 
0 
 
gpi1-S537/rtn1Δ 
 
- 
 
0/- 
 
0/- 
 
- 
 
gpi1-S537 
 
0/- 
 
0 
 
0/- 
 
- 
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Figure 4. Gpi1 interactions with rtn1Δ. 5X serial dilutions on YPD plates 
Figure5.  Gpi1 interactions with rtn2Δ. 5X serial dilutions on YPD plates 
30°                                                                       34° 
30°                                                                      34° 
15°                                                                             23° 
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Table 4: Rtn2 interactions with gpi1 mutants. Double mutants were generated and scored for 
growth against single mutants: “+” indicates rescue, “0/+” indicates partial rescue, “0” indicates 
that cells were viable “0/-” indicates partial sickness, “0/--” indicates extreme sickness, “-” 
indicates synthetic lethality. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
15° 
 
23° 
 
30° 
 
34° 
 
WT 
 
0 
 
0 
 
0 
 
0 
 
gpi1-S212 
 
0 
 
0 
 
0/- 
 
- 
 
gpi1-S212/rtn2Δ 
 
0 
 
0/- 
 
- 
 
- 
 
rtn2Δ 
 
0 
 
0 
 
0 
 
0 
 
gpi1-S537/rtn2Δ 
 
0/- 
 
0/+ (weak) 
 
0/- 
 
- 
 
gpi1-S537 
 
0/- 
 
0 
 
0/- 
 
- 
Chart 1: Summary of GPI1 growth interactions normalized to WT. 
Chart 1 : Summary of GPI1 growth interactions normalized to WT 
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NPC interactions with the Proteasome 
Previous lab data showed that the proteasome is responsible for NPC assembly as disruptions in 
rpt6, an ATPase of the proteasome resulted in a npa phenotype. The next sets of experiments 
performed were to observe the interactions between the rpt6 mutant in combination with various 
classes of npa mutants to further investigate the role of the proteasome in NPC assembly. Since 
RPT6 is an essential gene, mutational analysis by knockout was not possible. In order to bypass 
this, the endogenous promoter was replaced with a Tet-titratable promoter that allows the 
expression of the gene to be switched off by the addition of doxycycline. Double mutants were 
generated and assayed for growth on media containing Doxycycline (10µg/ml) at various 
temperatures. 
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Clustering mutant interactions with rpt6 
 
 
 
 
Nup120 and  Nup133 are non-essential nuclear pore proteins, that when disrupted, causes cells to  
exhibit a NPC clustering phenotype where the NPCs are concentrated in a discrete area of the 
nuclear envelope instead of being evenly distributed as seen in the WT cells. To test if these 
mutants have synergistic interactions with the rpt6 mutant, double mutant strains were generated 
by deleting the NUP120 and the NUP133 genes in the rpt6 mutants. The strains were assayed for 
growth at 15°,23°, 30°and 34°.  Positive interactions were observed at 30°and 34° where the 
temperature sensitive nup133Δ was rescued by the rpt6 mutant with the altered promoter (See 
Fig. 6). However, when RPT6 expression was eliminated by the addition of Dox, the nup133Δ 
did not rescue at any temperature. No synergistic interactions were observed with the nup120 Δ 
strains (See Fig. 6). 
15 
Dox+ 
15 
Dox- 
23 
Dox+ 
23 
Dox- 
30 
Dox+ 
30 
Dox- 
34 
Dox+ 
34 
D
ox
- 
 
WT 
0 0 0 0 0 0 0 0 
 
nup120Δ 
0/- 0/- 0/- 0/- 0/- 0/- - - 
 
nup120Δ 
/rpt6 
0/- 0/- 0/- 0/- 0/- 0/- - - 
 
nup133Δ 
0 0 0 0 0 0/-- 0 - 
 
nup133/rpt6 
- 0 - 0 - + - + 
 
rpt6 
- 0 - 0 - 0 - 0 
Table 6: rpt6 interactions with  nup120Δ and nup133Δ mutants. Double mutants were 
generated and scored for growth against single mutants: “+” indicates rescue, “0/+” indicates 
partial rescue, “0” indicates that cells were viable “0/-” indicates partial sickness, “0/--” indicates 
extreme sickness, “-” indicates synthetic lethality. 
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Nuclear Transport factors interactions with rpt6 
A second class of mutants with defective NPCs involves mutants in the nuclear transport factors 
kap95 and rna1. Both of these mutants have a temperature sensitive phenotype at 34°.  Double 
mutants were generated and assayed for growth on media containing YPD and YPD+ 
Doxycycline (10ug/ml) at various temperatures.  Partial negative interactions were observed in 
the kap95 rpt6 double mutant when compared to the single mutants. The double mutant grew 
worse than either of the singles at 23° and 30° on Dox- plates. The rna1 rpt6 also showed 
negative interactions at 34° on Dox-, as the double grew worse than either of the single mutants. 
Figure 6.  nup133Δ and nup120 Δ interactions with rpt6. 5X serial dilutions on YPD plates 
 
23°              30°                        34° 
WT 
nup133Δ 
nup133Δ rpt6 
rpt6 
 
WT 
rpt6 
nup120Δ 
nup120Δ rpt6 
 WT 
rpt6 
nup120Δ 
nup120Δ rpt6 
 
DOX+ 
DOX+ 
DOX- 
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No positive interactions were observed as neither of the nuclear transport factor mutants rescued 
the rpt6 mutant or vice versa. 
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Dox+ 
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Dox- 
30° 
Dox+ 
30° 
Dox- 
34° 
Dox+ 
34° 
Dox- 
 
WT 
0 0 0 0 0 0 
 
kap95 
0 0 0 0 - - 
 
kap95 /rpt6 
- 0/- - 0/- - - 
 
rpt6 
- 0 - 0 - 0 
 
rna1 
0 0 0 0 0 0 
 
rna1/rpt6 
- 0/- - 0 - 0/- 
D
o 
x
+ 
D
o 
x 
- 
WT 
kap95 
kap95 rpt6 
rpt6 
 WT 
kap95 
kap95 rpt6 
rpt6 
 Figure 7. kap95 interactions with rpt6. 5X serial dilutions on YPD and YPD+DOX plates 
23°             30°                        34° 
Table 6: rpt6 interactions with kap95and rna1 mutants. Double mutants were generated and 
scored for growth against single mutants: “+” indicates rescue, “0/+” indicates partial rescue, “0” 
indicates that cells were viable “0/-” indicates partial sickness, “0/--” indicates extreme sickness, 
“-” indicates synthetic lethality. 
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GPI anchor pathway interactions with rpt6 
The last class of NPC mutants tested in combination with rpt6 mutant were in the GPI anchor 
pathway. These mutants were assayed for growth at various temperatures. No synergistic 
interactions were observed as none of the GPI anchor mutants rescued the rpt6 mutant or vice 
versa. 
 
 
 
 
 
 
 
 
 
 
 
   
 
 
 
 
 
15° 
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Dox- 
 
23° 
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23° 
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30° 
Dox+ 
 
30° 
Dox- 
 
34° 
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34° 
Dox- 
 
WT 
0 0 0 0 0 0 0 0 
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0 0 0 0 0 0 0/- 0/- 
 
gab1/rpt6 
- 0/- - 0/- - 0 - - 
 
gpi1-
s212 
0 0 0 0 0/-- 0/- - - 
gpi1-
s212/rpt6 
 
- 0 - 0 - 0/-- - - 
gpi1-
s537 
 
0 0 0 0 00/- 0 - - 
 
gpi1-
s537/rpt6 
-  
0/- 
- 0/- 
 
 
- 
 
   -- 
- - 
 
rpt6 
- 0 - 0 - 0 - 0 
Table 7: rpt6 interactions with gab1, gpi1-s212 and gpi1-s537 mutants. Double mutants were 
generated and scored for growth against single mutants: “+” indicates rescue, “0/+” indicates 
partial rescue, “0” indicates that cells were viable “0/-” indicates partial sickness, “0/--” indicates 
extreme sickness, “-” indicates synthetic lethality. 
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Figure 7. rpt6 interactions with gpi1-S212 and gpi1-S537 . 5X serial dilutions on YPD and 
YPD+DOX plates 
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Figure 10.  rpt6 interactions with gab1 mutants. 5X serial dilutions on YPD and 
YPD+DOX plates 
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CHAPTER IV 
DISCUSSION 
 
The main focus of my research was to investigate NPC biogenesis by examining mutants that 
result in defective NPCs. This was done by examining mutants in the GPI anchor pathway and 
the proteasome.  
 
GPI anchor pathway  
First, I examined mutants in the GPI anchor pathway (gpi1) that resulted in mislocalized nups by 
testing two models: gpi1 mutants cause misregulation of N-linked glycosylation or gpi1 mutants 
alter membrane properties.  To test the first model, I combined gpi1 mutants with nup100Δ 
which has shown to relieve defects in a mutant with a similar phenotype to the gpi1 mutants. To 
test the second model, I combined gpi1 with mutants in membrane bending proteins (rtn1Δ and 
rtn2 Δ). Select double mutant of each class rescued the growth phenotype of the single mutants 
indicating that both of the models play a role in NPC assembly. The membrane bending 
synergistic effects of the gpi1 rtn1Δ and gpi1 rtn2 Δ mutants might be a result of altered lipid 
profiles in the NE. A lipid extraction assay can be performed which would confirm this 
hypothesis. 
 
Proteasome and NPC 
Since the rpt6 mutant has a severe npa phenotype with clustering of nucleoporins at a periphery 
of the NE along with NPC constituents trailing into the ER, I combined this mutant with various 
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other npa mutants to test to see if these aberrations could be relieved. These interactions would 
provide insight into factors required for NPC localization, assembly and organization. 
When rpt6 was combined with nup133Δ, positive interactions were seen as the altered promoter 
mutant rescued the temperature sensitive phenotype of the nup133Δ mutant. This was interesting, 
as this interaction was observed on regular media without doxycycline instead of the media with 
the doxycycline where rpt6 is completely down regulated. It is important to understand that 
though this interaction was seen on regular media, the results observed are still significant due to 
the altered promoter that changes gene expression levels. This altered promoter might have an 
increased or a decreased affinity for the RNA polymerase; thereby either increasing or 
decreasing the amount of mRNA produced. The altered mRNA expression levels will translate to 
the quantity of Rpt6 protein being produced. 
 
In a cell, there is a balance between the amount of a particular protein being produced by the 
ribosomes and protein turnover mediated by the proteasome.  In the altered promoter rpt6 
mutant, the degradation pathway is altered in such a way that there is either excess amount 
degradation due to increased catalytic activity of the proteasome or there not enough protein 
turnover due to a defective proteasome. The overall activity of the proteasome is linked to the 
amount of RPT6 mRNA being produced which is unknown. In order to measure the amount of 
mRNA produced, a reverse transcription PCR assay can be performed which will provide an 
estimate of RPT6 being made in the mutant strain versus the WT strain. Based on this, there are 
two possibilities that can explain why the altered promoter RPT6 can rescue the temperature 
sensitivity of the nup133Δ strain. 
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Hyperactive Proteasome/ Factor X hypothesis – Proteasomes are localized to the 
nucleus and the cytosol. The main function of the nuclear proteasome is to degrade 
oxidative damaged histones, various nuclear proteins. The deletion of nup133 gene has 
been shown to result in abnormal mRNA accumulation in the nucleus. Although there is 
no evidence for this, I propose that Nup133 functions as a transcription factor and affects 
“factor X” mRNA levels by down regulating its gene expression. In a nup133Δ single 
mutant, this interaction does not exist, resulting in “factor X” mRNA levels being 
expressed at higher levels than what is observed at WT. However in the nup133 Δ rpt6 
double mutant, the hyperactive proteasome which is the result of the altered promoter that 
produces excess RPT6 mRNA degrades “factor X’s” mRNA at higher levels, essentially 
duplicating NUP133’s function in “factor X’s” gene expression.  This would restore 
balance back to WT levels.   
Decreased proteasome activity hypothesis - mRNA is transcribed in the nucleus then 
exported out into the cytoplasm where it is translated by ribosomes to form a protein 
product. The turnover of this protein is mediated by the proteasome which has reduced 
activity in the altered promoter rpt6 mutant. This leads to an accumulation of the protein 
in the cytosol as it is not being constantly degraded. The nup133Δ causes an 
accumulation of mRNA in the nucleus. When this mRNA is not exported out to the 
cytosol, the protein concentration in the cytoplasm is effectively decreased as this mRNA 
cannot be translated by the ribosomes to form new protein. When nup133Δ is combined 
with an rpt6 mutant, the abnormal mRNA export defect of the nup133Δ is nullified by 
the defective proteasome function that fails to turn over the existing protein.  (See Fig. 
11). This model is much more plausible than the previous model. 
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The key to solving this is dependent on the activity level of the proteasome. The proteasome 
catalyzes degradation of proteins that have been tagged with a poly-ubiquitin chain.  To measure 
the activity level of the proteasome, ubiquitin can be fused to a β-Gal target that will eventually 
be directed to the proteasome for degradation. Since β-Gal activity is easily quantifiable, it will 
be a direct correlation of the level of proteasomal activity and provide evidence for one of the 
two models.   
 
The new interactions found between these complexes and pathways provide insight into different 
factors necessary for proper NPC biogenesis.  
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WT function.  
The proteasome is 
catalyzes protein 
turnover while the 
ribosomes make 
new proteins from 
fresh mRNAs that 
are being exported 
from the nucleus.  
 
rpt6 mutant 
The ineffective 
proteasome cannot 
catalyze protein 
turnover that leads 
to an aggregation 
of old and new 
protein.  
 
 
nup133Δ rpt6 
mutant 
Though the 
ineffective 
proteasome cannot 
catalyze protein 
turnover, fresh 
mRNAs are not 
being exported due 
to the nup133Δ 
defect.  
Figure 11. Decreased proteasome hypothesis 
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